Search results
Lots of drug companies talk about putting patients first — but this one actually did
WLRN Miami· 7 days agoIn April, the co-CEOs of Amylyx Pharmaceuticals fulfilled a promise they made years earlier to...
Congress evaluates how to lower prescription prices by increasing competition
KIRO via Yahoo News· 6 hours agoThey say big pharma has a limited period to sell a new drug before a generic version of it can hit...
California Senate passes drug pricing transparency, could slash health costs
The Center Square· 8 hours agoMarket-focused economists argue these groups engage in monopolistic practices that limit consumer...
AstraZeneca’s $80B sales plan leans on cancer drug expansion
BioPharma Dive via Yahoo Finance· 8 hours agoThe company already markets one, the breast cancer drug Enhertu, and has another now before...
Sanofi (SNY) Signs Deal for AI-Powered Drug Development
Zacks via Yahoo Finance· 10 hours agoPer the press release, the companies are collaborating to bring together data, software and tuned...
Congress evaluate how to lower prescription prices by increasing competition
WJAX via Yahoo News· 6 hours agoThey say big pharma has a limited period to sell a new drug before a generic version of it can hit...
French health groups put forward proposals to limit the damage of worsening drug shortages
Euronews via Yahoo News· 6 days agoPharmaceutical companies’ lack of transparency leads to rising drug prices and less control over...
... with YASKAWA to Create an Innovative Cell Therapy Ecosystem through the Integration of ...
FOX 23 News Albany· 22 hours agoAstellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that it signed a memorandum of understanding with YASKAWA Electric Corporation (YASKAWA) to begin ...
Ani Pharmaceuticals executive sells over $2.3 million in company stock By Investing.com
Investing.com· 4 days agoANI Pharmaceuticals Inc. (NASDAQ:ANIP) has reported a significant transaction involving its...
What's Going On With Biodexa Pharmaceuticals Stock? - Biodexa Pharmaceuticals (NASDAQ:BDRX)
Benzinga· 11 hours agoBiodexa Pharmaceuticals BDRX stock is trading higher. The company on Tuesday announced progress towards the treatment of Familial Adenomatous Polyposis.